JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Endocrinology (1992) 132, 433-438       DOI: 10.1677/joe.0.1320433
© 1992 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slootweg, M. C.
Right arrow Articles by Löwik, C. W. G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slootweg, M. C.
Right arrow Articles by Löwik, C. W. G. M.

Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I

 M. C. Slootweg, W. W. Most, E. van Beek, L. P. C. Schot, S. E. Papapoulos and C. W. G. M. Löwik

Insulin-like growth factor-I (IGF-I) is a potent stimulator of bone formation. Whether this growth factor also induces bone resorption has not been studied in detail. We used two organ culture systems to examine the direct effect of IGF-I on bone resorption. Fetal mouse radii/ulnae, containing mature osteoclasts, showed no response to IGF-I, indicating that osteoclastic activity is not influenced by IGF-I. Fetal mouse metacarpals/metatarsals, containing just osteoclast precursors and progenitors, showed an increase in resorption in response to IGF-I, indicating that IGF-I stimulates the formulation of osteoclast precursors/progenitors and thereby increases the number of osteoclasts.

Interleukin-6 (IL-6) has been hypothesized to be a mediator of bone resorptive agents such as parathyroid hormone (PTH). Both radii/ulnae and metacarpals/metatarsals reacted to IGF-I with an increase in IL-6 production. IL-6 production by UMR-106 osteogenic osteosarcoma cells was positively modulated by IGF-I, indicating that osteoblasts are likely to be the cells responsible for increased IL-6 production by the bones, and that IL-6 might be a mediatory of IGF-I-stimulated bone resorption.

Journal of Endocrinology (1992) 132, 433–438




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
T. Ueland
GH/IGF-I and bone resorption in vivo and in vitro
Eur. J. Endocrinol., March 1, 2005; 152(3): 327 - 332.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Santhanagopal and S. J. Dixon
Insulin-like growth factor I rapidly enhances acid efflux from osteoblastic cells
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E423 - E432.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg
Growth Hormone and Bone
Endocr. Rev., February 1, 1998; 19(1): 55 - 79.
[Abstract] [Full Text]

Home page
 CROBMHome page
H. Okada and S. Murakami
Cytokine Expression in Periodontal Health and Disease
Critical Reviews in Oral Biology & Medicine, January 1, 1998; 9(3): 248 - 266.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Franchimont, V. Gangji, D. Durant, and E. Canalis
Interleukin-6 with Its Soluble Receptor Enhances the Expression of Insulin-Like Growth Factor-I in Osteoblasts
Endocrinology, December 1, 1997; 138(12): 5248 - 5255.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the Society for Endocrinology.